These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21134647)

  • 1. Introduction. Local management of early-stage breast cancer.
    Pierce LJ
    Semin Radiat Oncol; 2011 Jan; 21(1):1-2. PubMed ID: 21134647
    [No Abstract]   [Full Text] [Related]  

  • 2. SEER data: it can be thought provoking, but where do we go from here?
    Petrelli NJ
    Ann Surg Oncol; 2007 Aug; 14(8):2173-4. PubMed ID: 17522940
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients.
    Tuttle TM; Habermann EB; Virnig B
    J Natl Cancer Inst; 2010 Sep; 102(17):1371-2; author reply 1372-3. PubMed ID: 20705935
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evidence-based radiotherapy in the treatment of operable breast cancer: results in the 1990-ies].
    Fodor J; Polgár C; Németh G
    Orv Hetil; 2000 Jul; 141(28):1551-5. PubMed ID: 10957865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced breast cancer in young women.
    Peres J
    J Natl Cancer Inst; 2013 Sep; 105(17):1257-8. PubMed ID: 23956454
    [No Abstract]   [Full Text] [Related]  

  • 6. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding tumor profiling and assessing treatment.
    Hyams DM
    Manag Care; 2008 Jul; 17(7 Suppl 7):4-8; discussion 17-8. PubMed ID: 19093336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiology of tumor markers in breast cancer management: prognostic markers.
    Page DL
    Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):101-4. PubMed ID: 8049630
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular predictors of local tumor control in early-stage breast cancer.
    Miyamoto DT; Harris JR
    Semin Radiat Oncol; 2011 Jan; 21(1):35-42. PubMed ID: 21134652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer: non-metastatic.
    Dixon JM; Gregory K; Johnston S; Rodger A
    Clin Evid; 2002 Jun; (7):1603-30. PubMed ID: 12230775
    [No Abstract]   [Full Text] [Related]  

  • 11. Breast cancer genomics: normal tissue and cancer markers.
    Schummer M; Beatty D; Urban N
    Ann N Y Acad Sci; 2010 Oct; 1210():78-85. PubMed ID: 20973801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical testing of supplementation therapy in early stage breast cancer: pitfalls and opportunities.
    Tripathy D
    Integr Cancer Ther; 2003 Jun; 2(2):160-2. PubMed ID: 15035905
    [No Abstract]   [Full Text] [Related]  

  • 13. Breast cancer.
    Buzdar AU; Hortobagyi GN
    Cancer Chemother Biol Response Modif; 1999; 18():435-69. PubMed ID: 10800497
    [No Abstract]   [Full Text] [Related]  

  • 14. Absolute risk models for subtypes of breast cancer.
    Gail MH; Anderson WF; Garcia-Closas M; Sherman ME
    J Natl Cancer Inst; 2007 Nov; 99(22):1657-9. PubMed ID: 18000214
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcomes of women with metachronous breast and ovarian carcinomas.
    Liou WS; Hamilton CA; Cheung MK; Osann K; Longacre TA; Teng NN; Husain A; Dirbas FM; Chan JK
    Gynecol Oncol; 2006 Oct; 103(1):190-4. PubMed ID: 16569424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000.
    Harlan LC; Clegg LX; Abrams J; Stevens JL; Ballard-Barbash R
    J Clin Oncol; 2006 Feb; 24(6):872-7. PubMed ID: 16484696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.
    Grann VR; Troxel AB; Zojwalla NJ; Jacobson JS; Hershman D; Neugut AI
    Cancer; 2005 Jun; 103(11):2241-51. PubMed ID: 15844176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [-Adjuvant systemic therapy of breast carcinoma-].
    Goldhirsch A; Castiglione-Gertsch M
    Arch Gynecol Obstet; 1995; 256 Suppl():S93-103. PubMed ID: 8619668
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of marital status on the stage at diagnosis, treatment, and survival of older women with breast cancer.
    Osborne C; Ostir GV; Du X; Peek MK; Goodwin JS
    Breast Cancer Res Treat; 2005 Sep; 93(1):41-7. PubMed ID: 16184457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.